Cargando…

Hypnotics and mortality in an elderly general population: a 12-year prospective study

BACKGROUND: Hypnotics are widely used by the elderly, and their impact on mortality remains controversial. The inconsistent findings could be due to methodological limitations, notably the lack of control for underlying sleep symptoms or illness associated with hypnotic use, for example, insomnia sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaussent, Isabelle, Ancelin, Marie-Laure, Berr, Claudine, Pérès, Karine, Scali, Jacqueline, Besset, Alain, Ritchie, Karen, Dauvilliers, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849429/
https://www.ncbi.nlm.nih.gov/pubmed/24070457
http://dx.doi.org/10.1186/1741-7015-11-212
_version_ 1782293922961162240
author Jaussent, Isabelle
Ancelin, Marie-Laure
Berr, Claudine
Pérès, Karine
Scali, Jacqueline
Besset, Alain
Ritchie, Karen
Dauvilliers, Yves
author_facet Jaussent, Isabelle
Ancelin, Marie-Laure
Berr, Claudine
Pérès, Karine
Scali, Jacqueline
Besset, Alain
Ritchie, Karen
Dauvilliers, Yves
author_sort Jaussent, Isabelle
collection PubMed
description BACKGROUND: Hypnotics are widely used by the elderly, and their impact on mortality remains controversial. The inconsistent findings could be due to methodological limitations, notably the lack of control for underlying sleep symptoms or illness associated with hypnotic use, for example, insomnia symptoms and excessive daytime sleepiness, depression and anxiety. Our objective was to examine the association between the use of hypnotics and mortality risk in a large cohort of community-dwelling elderly, taking into account a wide range of potential competing risks including sociodemographic characteristics, lifestyle, and chronic disorders as well as underlying psychiatric disorders and sleep complaints. METHODS: Analyses were carried out on 6,696 participants aged 65 years or older randomly recruited from three French cities and free of dementia at baseline. Adjusted Cox proportional hazards models with delayed entry, and age of the participants as the time scale, were used to determine the association between hypnotic use and 12-year survival. RESULTS: At baseline, 21.7% of the participants regularly used at least one hypnotic. During follow-up, 1,307 persons died, 480 from cancer and 344 from cardiovascular disease. Analyses adjusted for study center, age and gender showed a significantly greater risk of all-cause and cardiovascular-related mortality with hypnotics, particularly benzodiazepines, and this increased with the number of hypnotics used. None of these associations were significant in models adjusting for sociodemographic and lifestyle characteristics, chronic disorders including cardiovascular pathologies, sleep and psychiatric disorders. Results remained unchanged when duration of past hypnotic intake or persistent versus intermittent use during follow-up were taken into account. CONCLUSIONS: When controlling for a large range of potential confounders, the risk of mortality was not significantly associated with hypnotic use regardless of the type and duration. Underlying psychiatric disorders appear to be the principal confounders of the observed association.
format Online
Article
Text
id pubmed-3849429
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38494292013-12-06 Hypnotics and mortality in an elderly general population: a 12-year prospective study Jaussent, Isabelle Ancelin, Marie-Laure Berr, Claudine Pérès, Karine Scali, Jacqueline Besset, Alain Ritchie, Karen Dauvilliers, Yves BMC Med Research Article BACKGROUND: Hypnotics are widely used by the elderly, and their impact on mortality remains controversial. The inconsistent findings could be due to methodological limitations, notably the lack of control for underlying sleep symptoms or illness associated with hypnotic use, for example, insomnia symptoms and excessive daytime sleepiness, depression and anxiety. Our objective was to examine the association between the use of hypnotics and mortality risk in a large cohort of community-dwelling elderly, taking into account a wide range of potential competing risks including sociodemographic characteristics, lifestyle, and chronic disorders as well as underlying psychiatric disorders and sleep complaints. METHODS: Analyses were carried out on 6,696 participants aged 65 years or older randomly recruited from three French cities and free of dementia at baseline. Adjusted Cox proportional hazards models with delayed entry, and age of the participants as the time scale, were used to determine the association between hypnotic use and 12-year survival. RESULTS: At baseline, 21.7% of the participants regularly used at least one hypnotic. During follow-up, 1,307 persons died, 480 from cancer and 344 from cardiovascular disease. Analyses adjusted for study center, age and gender showed a significantly greater risk of all-cause and cardiovascular-related mortality with hypnotics, particularly benzodiazepines, and this increased with the number of hypnotics used. None of these associations were significant in models adjusting for sociodemographic and lifestyle characteristics, chronic disorders including cardiovascular pathologies, sleep and psychiatric disorders. Results remained unchanged when duration of past hypnotic intake or persistent versus intermittent use during follow-up were taken into account. CONCLUSIONS: When controlling for a large range of potential confounders, the risk of mortality was not significantly associated with hypnotic use regardless of the type and duration. Underlying psychiatric disorders appear to be the principal confounders of the observed association. BioMed Central 2013-09-26 /pmc/articles/PMC3849429/ /pubmed/24070457 http://dx.doi.org/10.1186/1741-7015-11-212 Text en Copyright © 2013 Jaussent et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jaussent, Isabelle
Ancelin, Marie-Laure
Berr, Claudine
Pérès, Karine
Scali, Jacqueline
Besset, Alain
Ritchie, Karen
Dauvilliers, Yves
Hypnotics and mortality in an elderly general population: a 12-year prospective study
title Hypnotics and mortality in an elderly general population: a 12-year prospective study
title_full Hypnotics and mortality in an elderly general population: a 12-year prospective study
title_fullStr Hypnotics and mortality in an elderly general population: a 12-year prospective study
title_full_unstemmed Hypnotics and mortality in an elderly general population: a 12-year prospective study
title_short Hypnotics and mortality in an elderly general population: a 12-year prospective study
title_sort hypnotics and mortality in an elderly general population: a 12-year prospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849429/
https://www.ncbi.nlm.nih.gov/pubmed/24070457
http://dx.doi.org/10.1186/1741-7015-11-212
work_keys_str_mv AT jaussentisabelle hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy
AT ancelinmarielaure hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy
AT berrclaudine hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy
AT pereskarine hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy
AT scalijacqueline hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy
AT bessetalain hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy
AT ritchiekaren hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy
AT dauvilliersyves hypnoticsandmortalityinanelderlygeneralpopulationa12yearprospectivestudy